FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Das Purkayastha

Research Profile

Disorders

Procedures

Chemicals & Drugs

Concepts & Ideas

Co-author Network

Publications

TOP 3
George L Bakris; Suzanne Oparil; Das Purkayastha; Thomas Alessi; Anthony M Yadao; James R Sowers
Randomized study of antihypertensive efficacy and safety of combination aliskiren/valsartan vs valsartan monotherapy in hypertensive participants with type 2 diabetes mellitus.
Elizabeth Ofili; Das Purkayastha; Rita Samuel; Dion H Zappe; James R Sowers
Antihypertensive and metabolic effects of Angiotensin receptor blocker/diuretic combination therapy in obese, hypertensive African American and white patients.
Prakash C Deedwania; Brent M Egan; Das Purkayastha; Rita Samuel; Dion H Zappe; James R Sowers
Does response of RAS blockade on serum K+ levels influence its glycemic-mitigating response when combined with hydrochlorothiazide?

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Das Purkayastha (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: George L Bakris; Suzanne Oparil; Das Purkayastha; Thomas Alessi; Anthony M Yadao; James R Sowers
Randomized study of antihypertensive efficacy and safety of combination aliskiren/valsartan vs valsartan monotherapy in hypertensive participants with type 2 diabetes mellitus.
Journal of clinical hypertension (Greenwich, Conn.) 2013;15(2):92-100.
2013: Elizabeth Ofili; Das Purkayastha; Rita Samuel; Dion H Zappe; James R Sowers
Antihypertensive and metabolic effects of Angiotensin receptor blocker/diuretic combination therapy in obese, hypertensive African American and white patients.
American journal of therapeutics 2013;20(1):2-12.
2012: Prakash C Deedwania; Brent M Egan; Das Purkayastha; Rita Samuel; Dion H Zappe; James R Sowers
Does response of RAS blockade on serum K+ levels influence its glycemic-mitigating response when combined with hydrochlorothiazide?
Journal of clinical hypertension (Greenwich, Conn.) 2012;14(7):415-21.
2012: Thomas D Giles; Das Purkayastha; Thomas Alessi; Dion H Zappe
Comparative efficacy of aliskiren/valsartan vs valsartan in nocturnal dipper and nondipper hypertensive patients: a pooled analysis.
Journal of clinical hypertension (Greenwich, Conn.) 2012;14(5):299-306.
2012: William C Cushman; Daniel A Duprez; Das Purkayastha; Rita Samuel; Howard S Weintraub; Dion Zappe; Joseph L Izzo
Home and clinic blood pressure responses in elderly individuals with systolic hypertension.
Journal of the American Society of Hypertension : JASH 2012;6(3):210-8.
2012: Keith C Ferdinand; Das Purkayastha; Kanaka Sridharan; Richard Weitzman; Edgar A Jaimes
Aliskiren-based dual- and triple-combination therapies in high-risk US minority patients with stage 2 hypertension.
Journal of the American Society of Hypertension : JASH 2012;6(3):219-27.
2012: Howard S Weintraub; Dion H Zappe; William C Cushman; Daniel A Duprez; Das Purkayastha; Rita Samuel; Joseph L Izzo
Antihypertensive response to thiazide diuretic or angiotensin receptor blocker in elderly hypertensives is not influenced by pretreatment plasma renin activity.
Cardiovascular drugs and therapy / sponsored by the International Society of Cardiovascular Pharmacotherapy 2012;26(2):145-55.
2012: John M Flack; Das Purkayastha; Rita Samuel; Anthony M Yadao; William B White
Comparison of the effects of aliskiren/valsartan in combination versus valsartan alone in patients with stage 2 hypertension.
Journal of the American Society of Hypertension : JASH 2012;6(2):142-51.
2011: Myron H Weinberger; Richard Weitzman; Joseph L Izzo; Das Purkayastha; Henry R Black
Comparative efficacy and safety of combination aliskiren/amlodipine and amlodipine monotherapy in African Americans with stage 2 hypertension and obesity or metabolic syndrome.
Journal of the American Society of Hypertension : JASH 2011;5(6):489-97.
2011: Leopoldo Raij; Rita Samuel; Brent M Egan; Das Purkayastha; Dion H Zappe; James R Sowers
Office and ambulatory blood pressure-lowering effects of combination valsartan/hydrochlorothiazide vs. hydrochlorothiazide-based therapy in obese, hypertensive patients.
Journal of clinical hypertension (Greenwich, Conn.) 2011;13(10):731-8.
2011: Joseph L Izzo; Das Purkayastha; Rita Samuel; Howard S Weintraub; Dion H Zappe; Daniel A Duprez; William C Cushman
Treating systolic hypertension in the very elderly with valsartan-hydrochlorothiazide vs. either monotherapy: ValVET primary results.
Journal of clinical hypertension (Greenwich, Conn.) 2011;13(10):722-30.
2011: Daniel A Duprez; William C Cushman; Das Purkayastha; Rita Samuel; Howard S Weintraub; Dion Zappe; Joseph L Izzo
Effect of valsartan, hydrochlorothiazide, and their combination on 24-h ambulatory blood pressure response in elderly patients with systolic hypertension: a ValVET substudy.
Blood pressure monitoring 2011;16(4):186-96.
2011: Elizabeth Ofili; Suzanne Oparil; Bertram Pitt; Das Purkayastha; Rita Samuel; Thomas Giles; Robert Hilkert; James R Sowers
Moderate versus intensive treatment of hypertension using amlodipine/valsartan and with the addition of hydrochlorothiazide for patients uncontrolled on angiotensin receptor blocker monotherapy: results in racial/ethnic subgroups.
Journal of the American Society of Hypertension : JASH 2011;5(4):249-58.
2011: Keith C Ferdinand; James Pool; Richard Weitzman; Das Purkayastha; Raymond Townsend
Peripheral and central blood pressure responses of combination aliskiren/hydrochlorothiazide and amlodipine monotherapy in African American patients with stage 2 hypertension: the ATLAAST trial.
Journal of clinical hypertension (Greenwich, Conn.) 2011;13(5):366-75.
2011: Thomas D Giles; Suzanne Oparil; Elizabeth Ofili; Bertram Pitt; Das Purkayastha; Robert Hilkert; Rita Samuel; James R Sowers
The role of ambulatory blood pressure monitoring compared with clinic and home blood pressure measures in evaluating moderate versus intensive treatment of hypertension with amlodipine/valsartan for patients uncontrolled on angiotensin receptor blocker monotherapy.
Blood pressure monitoring 2011;16(2):87-95.
2011: Bruce H Francis; Xue Song; L M Andrews; Das Purkayastha; Nicole Princic; Robert Sedgley; Amy E Rudolph
Progression to type 2 diabetes, healthcare utilization, and cost among pre-diabetic patients with or without comorbid hypertension.
Current medical research and opinion 2011;27(4):809-19.
2011: Keith C Ferdinand; Richard Weitzman; Marc Israel; Joleen Lee; Das Purkayastha; Edgar A Jaimes
Efficacy and safety of aliskiren-based dual and triple combination therapies in US minority patients with stage 2 hypertension.
Journal of the American Society of Hypertension : JASH 2011;5(2):102-13.
2010: Matthew R Weir; Anthony M Yadao; Das Purkayastha; Alan N Charney
Effects of high- and low-sodium diets on ambulatory blood pressure in patients with hypertension receiving aliskiren.
Journal of cardiovascular pharmacology and therapeutics 2010;15(4):356-63.
2010: Jackson T Wright; Yves Lacourcière; Rita Samuel; Dion Zappe; Das Purkayastha; Henry R Black
24-Hour ambulatory blood pressure response to combination valsartan/hydrochlorothiazide and amlodipine/hydrochlorothiazide in stage 2 hypertension by ethnicity: the EVALUATE study.
Journal of clinical hypertension (Greenwich, Conn.) 2010;12(11):833-40.
2010: James R Sowers; Leopoldo Raij; Ishwarlal Jialal; Brent M Egan; Elizabeth Ofili; Rita Samuel; Dion H Zappe; Das Purkayastha; Prakash C Deedwania
Angiotensin receptor blocker/diuretic combination preserves insulin responses in obese hypertensives.
Journal of hypertension 2010;28(8):1761-9.
2010: Inder S Anand; Anita Deswal; Dean J Kereiakes; Das Purkayastha; Dion H Zappe
Comparison of once-daily versus twice-daily dosing of valsartan in patients with chronic stable heart failure.
Vascular health and risk management 2010;6():449-55.
2009: Nathaniel Reichek; Richard B Devereux; Ricardo A Rocha; Robert Hilkert; Donna Hall; Das Purkayastha; Bertram Pitt
Magnetic resonance imaging left ventricular mass reduction with fixed-dose angiotensin-converting enzyme inhibitor-based regimens in patients with high-risk hypertension.
Hypertension 2009;54(4):731-7.
2009: Yves Lacourcière; Jackson T Wright; Rita Samuel; Dion Zappe; Das Purkayastha; Henry R Black
Effects of force-titrated valsartan/hydrochlorothiazide versus amlodipine/hydrochlorothiazide on ambulatory blood pressure in patients with stage 2 hypertension: the EVALUATE study.
Blood pressure monitoring 2009;14(3):112-20.
2008: William B White; David A Calhoun; Rita Samuel; Addison A Taylor; Dion H Zappe; Das Purkayastha
Improving blood pressure control: increase the dose of diuretic or switch to a fixed-dose angiotensin receptor blocker/diuretic? the valsartan hydrochlorothiazide diuretic for initial control and titration to achieve optimal therapeutic effect (Val-DICTATE) trial.
Journal of clinical hypertension (Greenwich, Conn.) 2008;10(6):450-8.
2007: Scott D Solomon; Rajesh Janardhanan; Anil Verma; Mikhail Bourgoun; William L Daley; Das Purkayastha; Yves Lacourcière; Stephen E. Hippler; Harold Fields; Tasneem Z Naqvi; Sharon L Mulvagh; J Malcolm O Arnold; James David Thomas; Michael R Zile; Gerard P Aurigemma
Effect of angiotensin receptor blockade and antihypertensive drugs on diastolic function in patients with hypertension and diastolic dysfunction: a randomised trial.
Lancet 2007;369(9579):2079-87.
2006: Emile R Mohler; David Herrington; Pamela Ouyang; Charles Mangano; Susan Ritter; Pamela Davis; Das Purkayastha; Marjorie Gatlin; Robert A Vogel
A randomized, double-blind trial comparing the effects of amlodipine besylate/benazepril HCl vs amlodipine on endothelial function and blood pressure.
Journal of clinical hypertension (Greenwich, Conn.) 2006;8(10):692-8.
2006: Rajesh Janardhanan; William L Daley; Tasneem Z Naqvi; Sharon L Mulvagh; Gerard P Aurigemma; Michael R Zile; J Malcolm O Arnold; Eunice Artis; Das Purkayastha; James David Thomas; Scott D Solomon
Rationale and design: the VALsartan In Diastolic Dysfunction (VALIDD) Trial: evolving the management of diastolic dysfunction in hypertension.
American heart journal 2006;152(2):246-52.
2006: Joel M Neutel; David H G Smith; Michael A Weber; Lesley Schofield; Das Purkayastha; Marjorie Gatlin
Efficacy of combination therapy with amlodipine besylate/benazepril hydrochloride for lowering systolic blood pressure in stage 2 hypertension.
The American journal of geriatric cardiology 2006;15(3):142-50.
2005: Joel M Neutel; David H G Smith; Michael A Weber; Lesley Schofield; Das Purkayastha; Marjorie Gatlin
Efficacy of combination therapy for systolic blood pressure in patients with severe systolic hypertension: the Systolic Evaluation of Lotrel Efficacy and Comparative Therapies (SELECT) study.
Journal of clinical hypertension (Greenwich, Conn.) 2005;7(11):641-6; quiz 647-8.
2005: John E Gerich; Philip Raskin; Lisa Jean-Louis; Das Purkayastha; Michelle A Baron
PRESERVE-beta: two-year efficacy and safety of initial combination therapy with nateglinide or glyburide plus metformin.
Diabetes care 2005;28(9):2093-9.
2004: Vivian A Fonseca; D E Kelley; W Cefalu; Michelle A Baron; Das Purkayastha; J E Nestler; S Hsia; John E Gerich
Hypoglycemic potential of nateglinide versus glyburide in patients with type 2 diabetes mellitus.
Metabolism: clinical and experimental 2004;53(10):1331-5.
2004: Kenneth A Jamerson; Oliseyenum Nwose; Lisa Jean-Louis; Lesley Schofield; Das Purkayastha; Michelle Baron
Initial angiotensin-converting enzyme inhibitor/calcium channel blocker combination therapy achieves superior blood pressure control compared with calcium channel blocker monotherapy in patients with stage 2 hypertension.
American journal of hypertension 2004;17(6):495-501.